Siemens Healthineers AG (OTCMKTS:SMMNY) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Siemens Healthineers AG (OTCMKTS:SMMNY) have been assigned an average rating of “Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, one has given a buy rating and three have given a strong buy rating to the company.

A number of brokerages have commented on SMMNY. Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft downgraded Siemens Healthineers from a “buy” rating to a “hold” rating in a research report on Thursday, December 4th.

Siemens Healthineers Stock Performance

SMMNY stock opened at $25.97 on Tuesday. The firm’s 50-day moving average is $26.22 and its two-hundred day moving average is $26.88. Siemens Healthineers has a 52 week low of $23.28 and a 52 week high of $30.19.

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.